228 related articles for article (PubMed ID: 38415252)
1. Unveiling the immune symphony: decoding colorectal cancer metastasis through immune interactions.
He R; Huang S; Lu J; Su L; Gao X; Chi H
Front Immunol; 2024; 15():1362709. PubMed ID: 38415252
[TBL] [Abstract][Full Text] [Related]
2. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer.
Zaravinos A; Roufas C; Nagara M; de Lucas Moreno B; Oblovatskaya M; Efstathiades C; Dimopoulos C; Ayiomamitis GD
J Exp Clin Cancer Res; 2019 Aug; 38(1):364. PubMed ID: 31429779
[TBL] [Abstract][Full Text] [Related]
3. Tumor-associated macrophages in colorectal cancer metastasis: molecular insights and translational perspectives.
Hou S; Zhao Y; Chen J; Lin Y; Qi X
J Transl Med; 2024 Jan; 22(1):62. PubMed ID: 38229160
[TBL] [Abstract][Full Text] [Related]
4. PD-1/PD-L1-dependent immune response in colorectal cancer.
Payandeh Z; Khalili S; Somi MH; Mard-Soltani M; Baghbanzadeh A; Hajiasgharzadeh K; Samadi N; Baradaran B
J Cell Physiol; 2020 Jul; 235(7-8):5461-5475. PubMed ID: 31960962
[TBL] [Abstract][Full Text] [Related]
5. Colorectal Cancer-Derived Small Extracellular Vesicles Promote Tumor Immune Evasion by Upregulating PD-L1 Expression in Tumor-Associated Macrophages.
Yin Y; Liu B; Cao Y; Yao S; Liu Y; Jin G; Qin Y; Chen Y; Cui K; Zhou L; Bian Z; Fei B; Huang S; Huang Z
Adv Sci (Weinh); 2022 Mar; 9(9):2102620. PubMed ID: 35356153
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer.
Chen QY; Chen YX; Han QY; Zhang JG; Zhou WJ; Zhang X; Ye YH; Yan WH; Lin A
Front Immunol; 2021; 12():679090. PubMed ID: 34054869
[TBL] [Abstract][Full Text] [Related]
7. The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer.
Subtil B; Cambi A; Tauriello DVF; de Vries IJM
Front Immunol; 2021; 12():724883. PubMed ID: 34691029
[TBL] [Abstract][Full Text] [Related]
8. How to overcome tumor resistance to anti-PD-1/PD-L1 therapy by immunotherapy modifying the tumor microenvironment in MSS CRC.
Chen L; Jiang X; Li Y; Zhang Q; Li Q; Zhang X; Zhang M; Yu Q; Gao D
Clin Immunol; 2022 Apr; 237():108962. PubMed ID: 35227870
[TBL] [Abstract][Full Text] [Related]
9. Immune Adaptation of Colorectal Cancer Stem Cells and Their Interaction With the Tumor Microenvironment.
Lin CC; Liao TT; Yang MH
Front Oncol; 2020; 10():588542. PubMed ID: 33312953
[TBL] [Abstract][Full Text] [Related]
10. The tumor microenvironment of colorectal cancer metastases: opportunities in cancer immunotherapy.
Kamal Y; Schmit SL; Frost HR; Amos CI
Immunotherapy; 2020 Oct; 12(14):1083-1100. PubMed ID: 32787587
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy for colorectal cancer: Rational strategies and novel therapeutic progress.
Rastin F; Javid H; Oryani MA; Rezagholinejad N; Afshari AR; Karimi-Shahri M
Int Immunopharmacol; 2024 Jan; 126():111055. PubMed ID: 37992445
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of colorectal liver metastasis development.
Shasha T; Gruijs M; van Egmond M
Cell Mol Life Sci; 2022 Nov; 79(12):607. PubMed ID: 36436127
[TBL] [Abstract][Full Text] [Related]
13. Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer.
Rizzo G; Bertotti A; Leto SM; Vetrano S
J Exp Clin Cancer Res; 2021 Jun; 40(1):178. PubMed ID: 34074330
[TBL] [Abstract][Full Text] [Related]
14. The Role of Tumor Microenvironment Cells in Colorectal Cancer (CRC) Cachexia.
Kasprzak A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557173
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite Instability and Immune Response: From Microenvironment Features to Therapeutic Actionability-Lessons from Colorectal Cancer.
Greco L; Rubbino F; Dal Buono A; Laghi L
Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372349
[TBL] [Abstract][Full Text] [Related]
16. Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects.
Makaremi S; Asadzadeh Z; Hemmat N; Baghbanzadeh A; Sgambato A; Ghorbaninezhad F; Safarpour H; Argentiero A; Brunetti O; Bernardini R; Silvestris N; Baradaran B
Biomedicines; 2021 Aug; 9(9):. PubMed ID: 34572263
[TBL] [Abstract][Full Text] [Related]
17. Cancer-Associated Fibroblasts Promote the Upregulation of PD-L1 Expression Through Akt Phosphorylation in Colorectal Cancer.
Gao Y; Sun Z; Gu J; Li Z; Xu X; Xue C; Li X; Zhao L; Zhou J; Bai C; Han Q; Zhao RC
Front Oncol; 2021; 11():748465. PubMed ID: 34868949
[TBL] [Abstract][Full Text] [Related]
18. Colorectal Cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting.
Aristin Revilla S; Kranenburg O; Coffer PJ
Front Immunol; 2022; 13():903564. PubMed ID: 35874729
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy and immunoevasion of colorectal cancer.
Al Zein M; Boukhdoud M; Shammaa H; Mouslem H; El Ayoubi LM; Iratni R; Issa K; Khachab M; Assi HI; Sahebkar A; Eid AH
Drug Discov Today; 2023 Sep; 28(9):103669. PubMed ID: 37328052
[TBL] [Abstract][Full Text] [Related]
20. Integrin-Linked Kinase Expression Characterizes the Immunosuppressive Tumor Microenvironment in Colorectal Cancer and Regulates PD-L1 Expression and Immune Cell Cytotoxicity.
Almasabi S; Boyd R; Ahmed AU; Williams BRG
Front Oncol; 2022; 12():836005. PubMed ID: 35692780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
